AI summary by TwinMind
Albert Bourla: Pfizer CEO | Lex Fridman Podcast #249
Lex Fridman
1h 8m 4s
Podcast Introduction and Context Setting
- Host Lex Fridman introduces conversation with Albert Bourla, Pfizer CEO
- Discusses two opposing groups claiming truth about institutions/companies
- Group 1: Only they possess truth, institutions will save you
- Group 2: Only they possess truth, institutions will hurt you
- Emphasizes vaccines saved hundreds of millions of lives historically
- Notes corrupting nature of power/money in institutions
- Host's position: COVID vaccine development = greatest scientific accomplishment in recent history
- Host took 2 Pfizer shots, supports individual choice without coercion
- Addresses integrity, independence from pressure/money/fame
November 8, 2020 - Phase 3 Results Day
- Pfizer team assembled in small Connecticut office (5 people)
- Waited for independent Data Monitoring Committee call
- Call came around 2 PM (later than expected, creating anxiety)
- Team drinking coffee, making jokes while waiting
- Bourla's reaction to successful results: "free, liberated, happy"
- Weight lifted from shoulders feeling
- Bourla told team "I love you" (Mediterranean communication style)
Vaccine Development Investment and Decision-Making
- Total investment: $2.3 billion (slightly over $2 billion)
- Typical process: spend $50M, then another $50M, then $100M incrementally
- COVID approach: "put all in" - risked everything at once to save time
- Decision context: pandemic fear, unprecedented situations, company capabilities
- Bourla's philosophy: focus on breakthrough value for patients, not money
- "If you focus too much on making money, you will never make money"
- "Focus on real value driver - breakthroughs that change patients' lives"
- Shareholders want patient-focused approach as only way to create value
Regulatory Process and FDA Transparency
- Studies highly regulated by FDA, European authorities, UK, Israeli, Japanese, Canadian authorities
- Well-established methodologies for proving efficacy and safety
- FDA 75-year data release request discussion
- Bourla: "I'm sure they have very good reasons"
- Host concerns about bureaucracy slowing transparency
- Rate of 500 pages/day review creating 75-year timeline
- Bourla emphasizes FDA transparency through detailed product specifications
- Acknowledges communication challenges but defends process integrity
FDA-Pfizer Relationship and Corruption Concerns
- Jordan Peterson's concern about close FDA-CDC-Pfizer working relationships
- Bourla: "Zero doubts" about regulatory bias
- System reinforcements: time barriers for industry-to-FDA moves
- Regulators "very very strict" and "unbiased"
- Internal processes with checks and balances
- External experts for difficult decisions
- Host's Soviet Union background creates corruption sensitivity
- Bourla: US regulatory agencies have "very good track record of integrity"
Public Trust and Pharmaceutical Industry Reputation
- Industry reputation "on the lowest that we have seen ever" in last decade
- "Reputation is something you can lose in buckets but earn back in drops"
- Industry behavior changes needed and implemented
- COVID demonstrated "power of science in hands of private sector"
- Private sector provided solutions: diagnostics, respirators, treatments, vaccines
- Positive impact on both sector and Pfizer reputation
- Must "earn it every day" - no complacency about improved reputation
2009 Bextra Case - Historical Context
- $2.3 billion settlement for illegal marketing of arthritis drug Bextra
- Events from 2003: several reps did off-label promotion
- Off-label promotion allowed physician-to-physician, not company-to-physician
- Fine based on revenue size, not severity
- "Stellar record" of compliance since 2009
- Internal processes prevent individual misconduct
- Company culture "sets aside people that think differently"
- Bourla: "didn't like what happened in 2003" but "a lot has changed"
Lawsuit Management and Doing Right
- Lawsuits inevitable due to "a lot of lawyers in the world"
- Philosophy: "try always to do the right thing"
- "If you don't do the right thing, sooner or later you will pay for it"
- Focus on innovations for real disease issues
- Exceed regulatory requirements for safety/efficacy
- Belief in justice system - "if you are doing the right thing, you will be on the right side of history"
Media Sponsorship and Influence Concerns
- Joe Rogan highlighted aggressive mainstream media marketing by Pfizer
- Bourla disputes "aggressive marketing" characterization
- TV ads "highly regulated" by FDA
- Required to state negative effects (often takes more time than positives)
- Sponsorship approach: "very few, very very few"
- Team reviews every sponsorship for conflict of interest
- Focus on patient-related organizations rather than media that could be perceived as influential
Vaccine Development Timeline and Process
- Previous vaccines take years - majority of time in Phase 3 study
- Phase 3 costs "almost a billion" - normally done incrementally to reduce risk
- COVID approach: "risked all the money" and "condensed all the time"
- Phase 3 study followed all normal rules
Development Phases Explained
- Started with 20 different vaccines, narrowed to 4, then 2, then 1
- Multiple dose testing to find optimal amount
- Animal experiments first, then small human doses
- Gradual dose increases while monitoring safety (reactogenicity)
- Immune response measurement throughout
- Multiple variables: vaccines, doses, schedules, age groups
- Phase 3: thousands of people, vaccine vs placebo
- Double-blind: neither patients nor physicians know which is administered
- Computer-controlled with dual-key access for data
- Monitor infection rates and safety profiles between groups
Scaling and Human Achievement
- Normal yearly vaccine production: 200 million doses
- COVID goal: 3 billion doses for new vaccine
- Treatment discovery normally 4 years, COVID: 4 months
- "Seemingly impossible" goals force out-of-box thinking
- Human ingenuity emerges when conventional approaches insufficient
- People "underestimate what they can do"
- Manufacturing scaled to 1 billion doses per quarter (4 billion annually)
Vaccine Safety Assurance
- "No medical product in history of humanity tested as much as this vaccine"
- Administered to hundreds of millions of people
- Constant scrutiny by healthcare authorities worldwide
- Electronic medical records monitoring vaccine recipients
- "Higher certainty that it is so safe" than any other product
- Warns against "misinformation spread on purpose"
Misinformation and Public Communication
- Host dislikes "misinformation" term due to Soviet Union experience
- Anyone can be labeled as spreading misinformation
- Bourla acknowledges science and data analytics as societal accomplishments
- Personal attacks on Bourla: false FBI arrest claims, fake wife death reports
- Calls to family in Greece to prevent panic from false news
- Acknowledges people profit from "stress and anxiety of good people"
- Both sides can profit from division and fear
Scientific Communication Failures
- Scientists disappointed host during COVID
- Lack of empathy in public science communication
- Scientists "talked down" to people without PhD/biology background
- Failed to acknowledge people's legitimate fears and concerns
- Parents worry about children, don't know who to trust
- People use "common sense" when uncertain about authority figures
- Bourla agrees: "humility is a virtue"
- Education doesn't guarantee humility, empathy, or good human qualities
- Need patience to "explain again and again" to earn trust
Vaccine Efficacy Communication
- Bourla careful about "100 percent" claims
- Always emphasizes "in biology there is nothing 100 percent"
- Small study numbers may show 100% efficacy
- Larger numbers typically show 95-96% efficacy
- Multiple review layers for public statements
- Maintains trust through careful, accurate communication
Booster Shot Evolution
- Initially: "we don't know" if boosters needed
- April-May data indicated boosters needed 8-12 months after second dose
- Then annual revaccinations predicted
- Delta variant moved timeline to 6 months
- Omicron variant may require 3-month intervals
- Two doses "might be challenging" with Omicron
- Three doses effective against Omicron
- Monitoring for potential Omicron-specific vaccine need
- Production capacity maintained at 4 billion doses annually
Vaccine Mandates
- "Very difficult topic" and "very difficult decision"
- Public health officials must decide, not pharmaceutical companies
- Pfizer employee mandate decision process
- Balanced fears of both vaccinated and unvaccinated employees
- Pfizer 90% vaccination rate pre-mandate, 96% post-mandate
- Flexible with health and religious exceptions
- Acknowledges serious debate with pros and cons
- Elected officials must make "difficult decisions"
Children's Vaccination
- Bourla supports vaccination for ages 5-16
- Pre-approval: more parents wanted vaccine for children
- Parents feared for unprotected children while family members protected
- Post-approval: smaller number afraid of vaccine rather than disease
- Emphasizes children do die and are hospitalized from COVID
- School disruptions from unvaccinated children getting infected
- Compares to polio vaccination - fewer kids hospitalized with polio than COVID
- "Shouldn't be a debate" - vaccines protect children from potential harm
Paxlovid Antiviral Development
- Developed in 4 months (normal discovery: 4 years)
- "Real game changer" - oral treatment for COVID patients
- 5-day course, twice daily pills
- Reduces hospitalization: 10 people normally hospitalized → 1 person
- 100% efficacy on deaths in studies (expects 99% in real world)
- Addresses hospital ICU capacity issues during surges
- Keeps people home instead of hospitalized
- Prevents postponement of elective surgeries
Ivermectin Discussion
- Scientists see "no reason" why antiparasitic drug would work on COVID
- No reliable peer-reviewed papers supporting ivermectin efficacy
- Compares to hydroxychloroquine - "how many people died because of that"
- Paxlovid studied in thousands of people under regulatory scrutiny
- Real-world monitoring will quickly show effectiveness
- Warns against unproven treatments delaying proper care
Hope for Future
- "Human ingenuity" as source of hope
- World "always progressing" despite problems
- 2020 society better than 50-100 years ago in all aspects
- Poverty, human rights, science, quality of life improvements
- "Humans can create and always create a better future"
Mortality and Meaning
- Initially "fearless of death" when young
- Having children changed perspective - wants to see their weddings, grandchildren
- Fear of not being part of children's lives
- Hopes for afterlife to watch from "upstairs"
- Quotes Steve Jobs: "Death is life's biggest invention"
- Death "eliminates the old and gives place to the new"
- Life about "moving forward" and "creating new things"
- "Everyone is a contributor but no one is the owner"
- Always "adding something beautiful into the world"
